Mitsubishi Tanabe Pharma Corporation
田辺三菱製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4508
FY2018 · 2019-03-31
| Gross margin | 57.5% |
| Operating margin | 11.8% |
| Net margin | 8.8% |
| Return on equity | 4.2% |
| Return on assets | 3.5% |
| Revenue growth (YoY) | -2.1% |
| EPS (basic) | ¥66.64 |
| EPS growth (YoY) | -35.5% |
| Current ratio | — |
| Equity ratio | 85.0% |
| Book value / share | ¥1,460.69 |
| Free cash flow | 35,730 M |